Cabot - CBT Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

4 analysts have issued 1-year price objectives for Cabot's stock. Their CBT share price forecasts range from $72.00 to $86.00. On average, they expect the company's stock price to reach $79.25 in the next year. This suggests a possible upside of 20.3% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $56.20 at the start of the year. Since then, CBT stock has increased by 17.2% and is now trading at $65.87.
View the best growth stocks for 2022 here.

Cabot saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 1,390,000 shares, a decline of 9.7% from the August 15th total of 1,540,000 shares. Based on an average daily volume of 333,600 shares, the days-to-cover ratio is presently 4.2 days. Currently, 2.5% of the company's shares are sold short.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) posted its quarterly earnings results on Monday, August, 8th. The specialty chemicals company reported $1.73 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.20. The specialty chemicals company earned $1.15 billion during the quarter, compared to analyst estimates of $1.05 billion. Cabot had a net margin of 3.50% and a trailing twelve-month return on equity of 32.30%. The firm's revenue for the quarter was up 25.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.35 earnings per share.

Cabot announced a quarterly dividend on Friday, July 8th. Shareholders of record on Friday, August 26th will be paid a dividend of $0.37 per share on Friday, September 9th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Thursday, August 25th.
Read our dividend analysis for CBT.

Cabot (NYSE:CBT) pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.25%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 60.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 20.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

Cabot issued an update on its FY 2022 earnings guidance on Monday, September, 5th. The company provided earnings per share (EPS) guidance of $6.10-$6.20 for the period, compared to the consensus earnings per share estimate of $6.14. The company issued revenue guidance of -.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (4.94%), State Street Corp (3.19%), Victory Capital Management Inc. (1.33%), Northern Trust Corp (1.33%), Goldman Sachs Group Inc. (1.07%) and Sei Investments Co. (0.79%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $65.87.

Cabot (NYSE:CBT) has a market capitalization of $3.71 billion and generates $3.41 billion in revenue each year. The specialty chemicals company earns $250 million in net income (profit) each year or $2.46 on an earnings per share basis.

The company employs 4,500 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.